100397-96-4

Basic information

• Product Name: 1-(4-BROMO-PHENYL)-2-PYRIDIN-4-YL-ETHANONE
• Synonyms: 1-(4-BROMO-PHENYL)-2-PYRIDIN-4-YL-ETHANONE;1-(4-BroMophenyl)-2-(4-pyridinyl)-ethanone
• CAS NO: 100397-96-4
• Molecular Formula: C₁₃H₁₀BrNO
• Molecular Weight: 276.13
• Mol File: 100397-96-4.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 1-(4-BROMO-PHENYL)-2-PYRIDIN-4-YL-ETHANONE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-BROMO-PHENYL)-2-PYRIDIN-4-YL-ETHANONE(100397-96-4)
• EPA Substance Registry System: 1-(4-BROMO-PHENYL)-2-PYRIDIN-4-YL-ETHANONE(100397-96-4)

Safety Data

• Hazardous Substances Data: 100397-96-4(Hazardous Substances Data)

Usage

General Description

1-(4-Bromo-phenyl)-2-pyridin-4-yl-ethanone is a chemical compound with the molecular formula C14H10BrNO. It is a ketone derivative containing a pyridine ring and a bromophenyl group. 1-(4-BROMO-PHENYL)-2-PYRIDIN-4-YL-ETHANONE is often used as a building block in organic synthesis, particularly in the production of pharmaceuticals, agrochemicals, and other fine chemicals. Its specific properties and uses depend on the intended application and the reactions in which it is involved.

Upstream product

• 40774-05-8 1-(2,6-dichloro-benzyl)-pyridinium; bromide 
• 99-90-1 para-bromoacetophenone 
• 108-89-4 picoline 
• 192436-83-2 4-bromo-N-methoxy-N-methylbenzamide 
• 586-76-5 4-Bromobenzoic acid 
• 109399-93-1 1-(4-bromo-phenyl)-2-[1-(2,6-dichloro-benzyl)-1H-[4]pyridyliden]-ethanone 
• 623-00-7 4-bromobenzenecarbonitrile 

Downstream Products

• 1422842-10-1 C₁₅H₁₃N₃S 
• 1422842-13-4 C₁₅H₁₃N₃S 
• 1422841-43-7 C₂₆H₂₂N₄OS 
• 1422841-45-9 C₂₆H₂₂N₄OS 
• 1422841-48-2 C₂₆H₂₂N₄OS 
• 1422841-49-3 C₂₆H₂₂N₄OS 
• 1422841-68-6 C₂₆H₂₂N₄OS 
• 1422841-71-1 C₂₆H₂₂N₄OS 
• 1422841-72-2 C₂₆H₂₂N₄OS 
• 1422841-75-5 C₂₆H₂₂N₄OS 
• 1422842-14-5 C₂₃H₁₆N₄O₂ 
• 1422842-15-6 C₁₅H₁₄N₄ 
• 1422841-50-6 C₂₆H₂₃N₅O 
• 1422841-53-9 C₂₆H₂₃N₅O 

Relevant articles and documents

NOVEL INHIBITOR COMPOUNDS OF PHOSPHODIESTERASE TYPE 10A

The present invention relates to compounds of the formula I and their salts etc. which are inhibitors of phosphodiesterase type 10A and to their use for the manufacture of a medicament and which thus are suitable for treating or controlling of medical disorders selected from neurological disorders and psychiatric disorders, for ameliorating the symptoms associated with such disorders and for reducing the risk of such disorders. wherein Y1 and Y2 are adjacent atoms in Het1, which are independently selected from the group consisting of carbon and nitrogen; k is 0, 1, 2 or 3; Het1 is a bivalent monocyclic 5- or 6-membered heteroaromatic radical, having 1, 2 or 3 heteroatoms or heteroatom moieties selected from O, S, N and N—Ra as ring members, or a bivalent fused bicyclic 8-, 9- or 10-membered heteroaromatic radical, having 1, 2, 3 or 4 heteroatoms or heteroatom moieties selected from O, S, N and N—Ra as ring members; Het2 is inter alia monocyclic 5- or 6-membered hetaryl, having 1, 2 or 3 heteroatoms or heteroatom moieties selected from O, S, N and N—R1a as ring members, Cyc is inter alia optionally substituted monocyclic 5- or 6-membered hetaryl or optionally substituted fused 8-, 9- or 10-membered bicyclic hetaryl; Ar is optionally substituted phenylene or optionally substituted bivalent 6-membered hetaryl; R is attached to a carbon atom of Het1 and inter alia-halogen, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkoxy, C1-C6-fluoroalkyl, C1-C6-fluoroalkoxy, C3-C6-cycloalkyl etc.

ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF

This invention relates to novel alkyne-bridged hetero-aromatics as described in the specification which are PDE10A inhibitors and useful for the treatment of neurological, psychiatric disorder, metabolic disorders, such as Schizophrenia, Parkinson's disea